Olga Voroshilova, MD | |
224 W Exchange St Ste 330, Akron, OH 44302-1715 | |
(330) 436-3150 | |
Not Available |
Full Name | Olga Voroshilova |
---|---|
Gender | Female |
Speciality | Nephrology |
Experience | 27 Years |
Location | 224 W Exchange St Ste 330, Akron, Ohio |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1447248794 | NPI | - | NPPES |
0107602Y0NH01 | Other | NH | ANTHEM |
0489817 | Medicaid | OH | |
30200256 | Medicaid | NH | |
G95474 | Other | NH | HARVARD PILGRIM |
QX3345 | Other | NH | MEDICARE PTAN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RN0300X | Internal Medicine - Nephrology | 10635 (New Hampshire) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Davita - Summit Renal Care | Akron, OH | Dialysis facility |
Fmc - Akron | Akron, OH | Dialysis facility |
Davita - Munroe Falls | Munroe falls, OH | Dialysis facility |
Fmc - Bio-medical Applications Of Ohio, Inc. | Akron, OH | Dialysis facility |
Akron General Medical Center | Akron, OH | Hospital |
Summa Health System | Akron, OH | Hospital |
Western Reserve Hospital | Cuyahoga falls, OH | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Americare Kidney Institute Llc | 9133356843 | 23 |
News Archive
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that it has submitted a supplemental new drug application (sNDA) to the U.S. Food and Drug Administration (FDA) requesting approval for the use of ENTEREG® (alvimopan) to accelerate GI recovery following any surgery that includes a bowel resection with primary anastomosis; expanded from the current indication in patients requiring surgery for colorectal disease.
IDEV Technologies, Incorporated (IDEV), an emerging leader in the development and marketing of minimally invasive medical technologies, today announced that it has entered into an exclusive distribution agreement covering the U.S. and Germany for TriReme Medical, Inc.'s (TriReme) GliderXtreme™ PTA balloon catheter, an advanced product with specific features for the expanding Peripheral Arterial Disease (PAD) market.
The U.S. Food and Drug Administration today approved a new device that provides neurointerventional surgeons with another tool to treat brain aneurysms without performing open surgery.
The latest study, by a group called the Partnership for a Drug-Free America, has found that approximately one in five teenagers have tried to get high by using prescription painkillers such as Vicodin and OxyContin which they often find in their parents' medicine cabinets.
GENova Biotherapeutics Inc. ("GENova") today announced that it has signed a LOI for a strategic partnership agreement with the Hospital Medical Information Department of Suncheon Cheongam University in Seoul, South Korea to gain access to its ground-breaking cancer stem cell research information.
› Verified 8 days ago
Entity Name | Americare Kidney Institute Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1013349471 PECOS PAC ID: 9133356843 Enrollment ID: O20131227001669 |
News Archive
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that it has submitted a supplemental new drug application (sNDA) to the U.S. Food and Drug Administration (FDA) requesting approval for the use of ENTEREG® (alvimopan) to accelerate GI recovery following any surgery that includes a bowel resection with primary anastomosis; expanded from the current indication in patients requiring surgery for colorectal disease.
IDEV Technologies, Incorporated (IDEV), an emerging leader in the development and marketing of minimally invasive medical technologies, today announced that it has entered into an exclusive distribution agreement covering the U.S. and Germany for TriReme Medical, Inc.'s (TriReme) GliderXtreme™ PTA balloon catheter, an advanced product with specific features for the expanding Peripheral Arterial Disease (PAD) market.
The U.S. Food and Drug Administration today approved a new device that provides neurointerventional surgeons with another tool to treat brain aneurysms without performing open surgery.
The latest study, by a group called the Partnership for a Drug-Free America, has found that approximately one in five teenagers have tried to get high by using prescription painkillers such as Vicodin and OxyContin which they often find in their parents' medicine cabinets.
GENova Biotherapeutics Inc. ("GENova") today announced that it has signed a LOI for a strategic partnership agreement with the Hospital Medical Information Department of Suncheon Cheongam University in Seoul, South Korea to gain access to its ground-breaking cancer stem cell research information.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Olga Voroshilova, MD 1662 Mars Ave, Lakewood, OH 44107-3825 Ph: (216) 712-6556 | Olga Voroshilova, MD 224 W Exchange St Ste 330, Akron, OH 44302-1715 Ph: (330) 436-3150 |
News Archive
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that it has submitted a supplemental new drug application (sNDA) to the U.S. Food and Drug Administration (FDA) requesting approval for the use of ENTEREG® (alvimopan) to accelerate GI recovery following any surgery that includes a bowel resection with primary anastomosis; expanded from the current indication in patients requiring surgery for colorectal disease.
IDEV Technologies, Incorporated (IDEV), an emerging leader in the development and marketing of minimally invasive medical technologies, today announced that it has entered into an exclusive distribution agreement covering the U.S. and Germany for TriReme Medical, Inc.'s (TriReme) GliderXtreme™ PTA balloon catheter, an advanced product with specific features for the expanding Peripheral Arterial Disease (PAD) market.
The U.S. Food and Drug Administration today approved a new device that provides neurointerventional surgeons with another tool to treat brain aneurysms without performing open surgery.
The latest study, by a group called the Partnership for a Drug-Free America, has found that approximately one in five teenagers have tried to get high by using prescription painkillers such as Vicodin and OxyContin which they often find in their parents' medicine cabinets.
GENova Biotherapeutics Inc. ("GENova") today announced that it has signed a LOI for a strategic partnership agreement with the Hospital Medical Information Department of Suncheon Cheongam University in Seoul, South Korea to gain access to its ground-breaking cancer stem cell research information.
› Verified 8 days ago
Dr. Michael A Pelini, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 95 Arch St, Ste 300, Akron, OH 44304 Phone: 330-376-7000 Fax: 330-376-1066 | |
David P. Lang, M.D. Nephrology Medicare: Not Enrolled in Medicare Practice Location: 4125 Medina Rd, #200c, Akron, OH 44333 Phone: 330-665-8031 Fax: 330-665-8360 | |
Ms. Tiffany Mccann, D.O. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 525 E Market St, Akron, OH 44304 Phone: 330-375-3561 | |
Jonathan Buggey, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 95 Arch St Ste 300, Akron, OH 44304 Phone: 724-422-6808 | |
Shamsa Baaj, MD Nephrology Medicare: Medicare Enrolled Practice Location: 1 Akron General Ave, Akron, OH 44307 Phone: 330-344-6000 | |
Mira Rohit Patel, DO Nephrology Medicare: Medicare Enrolled Practice Location: 161 N Forge St Ste 198, Akron, OH 44304 Phone: 330-375-3039 | |
Richard J Streck, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 400 Wabash Ave, 5th Floor Ambulatory Care Center, Akron, OH 44307 Phone: 330-344-6015 Fax: 330-344-6820 |